[73] Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as first-line therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria
Objective: To investigate the effectiveness of sunitinib as first-line therapy in real-world practice in terms of progression-free survival (PFS), objective response rate (ORR), and overall survival (OS), and to evaluate the safety profile for advanced or metastatic clear-cell renal cell carcinoma (...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/5ecc5685575f4e83ab3b6de9d0f97b37 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|